Pralidoxime has 2 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Atropine, Atropine Sulfate Injection Usp, 0.5 Mg/0.7 Ml. Patients taking Pralidoxime should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Moderate
- 2
Moderate (2)
- Pralidoxime + Atropine— Pralidoxime may potentiate atropine effect, causing earlier onset of atropinization signs (flushing, mydriasis, tachycar…
- Pralidoxime + Atropine Sulfate Injection Usp, 0.5 Mg/0.7 Ml— Pralidoxime may potentiate the effect of atropine, causing signs of atropinization (flushing, mydriasis, tachycardia, dr…